Elegen is a biotechnology company that develops microfluidic technology.
Elegen has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
Elegen's investors include Andreessen Horowitz, 8VC, Triatomic Capital, Agilent Technologies, KdT Ventures.
Elegen is headquartered in San Carlos, United States.
Elegen is a biotechnology company that develops microfluidic technology.
Elegen is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elegen — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/elegen. Accessed July 19, 2026.
VCBacked. (2024). Elegen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/elegen
{{cite web |title=Elegen — Funding & Investors |url=https://www.vcbacked.co/company/elegen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated